• Journal Article

Cost-utility analysis of treatments for advanced non-small cell lung cancer

Citation

Lairson, D. R., Parikh, R., Cormier, J. N., Wenyaw, C., & Du, X. L. (2015). Cost-utility analysis of treatments for advanced non-small cell lung cancer. American Journal of Pharmacy Benefits, 7(6), 271-9.

Abstract

Platinum-based chemotherapy may be cost-effective compared with no chemotherapy for the overall elderly population and by age group. However, platinum + targeted therapy was not cost-effective compared with the use of platinum-based therapy alone.